COLLEEN E PARENT

Allopathic & Osteopathic Physicians|Family Medicine ALBANY, NY NPI 1821293598

General Payments — all program years on this page

$2,352.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 124
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $209.31 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $209.3110

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Indivior Inc. $49.942
Gilead Sciences, Inc. $45.212
Alkermes, Inc. $40.672
Orexo US, Inc. $33.692
Acerta Pharma LLC $20.451
Neurocrine BioSciences, Inc. $19.351

By program year

Program yearAmountRecords
2018 $88.855
2019 $95.017
2020 $282.9118
2021 $975.1759
2022 $478.2615
2023 $223.1110
2024 $209.3110

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105562476 AstraZeneca Pharmaceuticals LP $20.45 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120569661 Alkermes, Inc. $19.18 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120569663 Alkermes, Inc. $21.49 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739320 Gilead Sciences, Inc. $25.62 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739322 Gilead Sciences, Inc. $19.59 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136176131 Orexo US, Inc. $14.90 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136179704 Orexo US, Inc. $18.79 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144535021 Indivior Inc. $24.58 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144535023 Indivior Inc. $25.36 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150861169 Neurocrine Biosciences, Inc. $19.35 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.